http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-590113-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12cedce8d26d81271038993ba4912fe6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00 |
| filingDate | 1944-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1947-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-590113-A |
| titleOfInvention | Improvements in or relating to the production of hydrogenated oestiogenic hormone sulphates |
| abstract | 17-Hydroxy steroid 3-monosulphates are prepared by subjecting a 17-keto steroid-3-monosulphate alone or in admixture with other substances to the action of catalytically activated hydrogen. The reduction is preferably carried out in neutral or mildly alkaline aqueous solution under substantially normal conditions of temperature and pressure. The preferred catalyst is platinum oxide. The products may be isolated as water-soluble sodium salts or insoluble quinidine salts. In examples: (1) sodium oestrone sulphate is hydrogenated at room temperature in the presence of platinum oxide catalyst and M/5 phosphate buffer to form sodium oestradiol-3-monosulphate; (2) as in example (1) with varying experimental conditions; (3) as in example (1) but using as the starting material a mixture of the oestrogenic sulphates isolated from equine urine. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4113751-A |
| priorityDate | 1943-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.